CMG Pharmaceutical Co., Ltd. (KOSDAQ:058820)
South Korea flag South Korea · Delayed Price · Currency is KRW
730.00
-70.00 (-8.75%)
Jul 28, 2026, 3:30 PM KST

CMG Pharmaceutical Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2019
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '19
Cash & Equivalents
9,1836,1232,5881,2434,45618,571
Short-Term Investments
17,39620,37974,20667,58573,35739,000
Trading Asset Securities
-----62,003
Cash & Short-Term Investments
26,57926,50276,79468,82777,813119,574
Cash Growth
-64.20%-65.49%11.58%-11.55%-34.92%119.54%
Accounts Receivable
34,64434,71531,31223,32021,33020,291
Other Receivables
913.5637.151,174929.561,143869.89
Receivables
35,56535,36032,48624,25034,54221,161
Inventory
28,12329,54223,78820,57021,2709,049
Prepaid Expenses
2,6062,752141.95150.35143.371.04
Other Current Assets
1,0361,0221,6491,9401,301729.16
Total Current Assets
93,90995,179134,859115,737135,070150,584
Property, Plant & Equipment
126,534114,99477,97750,71137,47224,119
Long-Term Investments
57,28855,52546,46352,56522,9964,003
Goodwill
2,2742,2742,2742,274--
Other Intangible Assets
3,2693,4372,9083,6753,1051,339
Long-Term Deferred Tax Assets
5,5105,5083,3152,9732,6032,006
Long-Term Deferred Charges
12,99712,76116,37213,62711,2829,736
Other Long-Term Assets
486.37477.9291.94456.59621.92455.44
Total Assets
319,327305,962303,437242,098213,260192,243

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2019
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '19
Accounts Payable
8,8069,58112,0139,19711,2454,328
Accrued Expenses
2,0251,8263,1983,2042,9172,054
Short-Term Debt
46,54946,72144,068880--
Current Portion of Long-Term Debt
-025,0000---
Current Portion of Leases
137.61142.68221.4206.16356.41129.64
Current Income Taxes Payable
-161.54--99.45-
Other Current Liabilities
17,82220,22415,14511,0427,2852,794
Total Current Liabilities
75,340103,65674,64524,52921,9039,306
Long-Term Debt
41,500-35,43624,7016,000-
Long-Term Leases
109.97144.85240.26332.07356.43156.76
Pension & Post-Retirement Benefits
522.49467.921,091753.79-1,057
Other Long-Term Liabilities
138.05138.052,4831,55048.381,565
Total Liabilities
117,610104,407113,89551,86628,30712,085

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2019
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '19
Common Stock
73,92173,92169,44669,44669,44669,446
Additional Paid-In Capital
122,573122,556104,889104,641104,641104,812
Retained Earnings
4,7764,64413,89414,2199,0005,055
Comprehensive Income & Other
446.98433.391,3131,9261,866845.23
Shareholders' Equity
201,717201,555189,542190,233184,953180,158
Total Liabilities & Equity
319,327305,962303,437242,098213,260192,243

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2019
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '19
Total Debt
88,29672,00879,96526,1196,713286.39
Net Cash (Debt)
-61,717-45,506-3,17142,70871,100119,288
Net Cash Growth
----39.93%-40.40%119.02%
Net Cash Per Share
-427.57-315.51-5.88307.49511.91981.40
Filing Date Shares Outstanding
147.84147.84138.89138.89138.89138.89
Total Common Shares Outstanding
147.84147.84138.89138.89138.89138.89
Working Capital
18,570-8,47760,21491,208113,167141,278
Book Value Per Share
1364.411363.311364.671369.641331.631297.11
Tangible Book Value
196,174195,844184,360184,284181,848178,820
Tangible Book Value Per Share
1326.921324.691327.361326.811309.281287.47
Land
19,57519,57519,5743,9852,7092,709
Buildings
8,20312,68012,31211,00410,74110,741
Machinery
3,57118,93719,59218,42116,93414,678
Construction In Progress
94,34082,46644,61734,09422,5797,511